As of now, Eagle Eye Technology’s products have covered multiple scenarios including hospitals, primary medical institutions, and optometry centers. In the first half of the year, the number of its active service outlets increased significantly by 78.6% to 5,950 from 3,331 in the same period last year.
With the continuous commercialization of its products, Eagle Eye Technology has ushered in highquality growth in performance. Data shows that in the first half of the year, Eagle Eye Technology achieved revenue of RMB iceland phone number list 93.71 million, a yearonyear increase of 13.6%. The gross profit reached 53.756 million yuan, and the gross profit margin was 57.4%. From this perspective, with the support of continuous technological innovation, the company is gradually releasing huge commercial value. Excellent financial data can also attract more attention from investors, thereby bringing higher visibility and brand exposure, and driving the simultaneous improvement of corporate brand value and investment value.
In recent years, AI medical imaging has shown significant growth in helping doctors identify problems and assisting them in diagnosis and treatment. At the same time, governments around the world are interested in promoting the development of AI medical technology by actively introducing various support policies, thereby pushing global AI medical care into a rapid development stage.
Taking the United States as an example, the FDA has broken the restrictions on AI products in traditional medical device approval policies, and has established a separate AI and Digital Healthcare Review Department. It has also accelerated the approval of AI medical products by lowering the threshold for medical AI products.